Literature DB >> 9754794

Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.

U Eder1, R Fischer-Colbrie, P Kogner, B Leitner, P Bjellerup, H Winkler.   

Abstract

The chromogranins are a class of acidic proteins found in large secretory granules of neuroendocrine tissues and tumors derived from them. We measured the relative amounts and characterized the molecular forms of two members of this family, i.e. chromogranin A and secretogranin II, in 14 neuroblastomas and five ganglioneuromas. In all the tumors investigated significant amounts of chromogranin A and secretogranin II were found. Neuroblastomas contained two times and ganglioneuromas 45 times more secretogranin II compared to chromogranin A. Both proteins were processed in these tumors to a great extent to smaller peptides, only limited amounts of intact chromogranin A or secretogranin II were present. In general, proteolytic processing of secretogranin II to the small neuropeptide secretoneurin was more complete than that of chromogranin A to the peptide GE-25. Proteolytic processing of both chromogranins as well as the total amounts of these proteins were unrelated to tumor staging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754794     DOI: 10.1016/s0304-3940(98)00588-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.

Authors:  K C Tsao; G H Liu; P Y Chang; C N Lin; T L Wu; C F Sun; J T Wu
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.

Authors:  Giovanni Gori; Giacomo Spinelli; Claudio Spinelli; Marco Tuccori; Corrado Blandizzi; Mario Del Tacca
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

4.  Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.

Authors:  Johann Guillemot; Marlène Guérin; Erwan Thouënnon; Maité Montéro-Hadjadje; Jérôme Leprince; Hervé Lefebvre; Marc Klein; Mihaela Muresan; Youssef Anouar; Laurent Yon
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.